Presentation is loading. Please wait.

Presentation is loading. Please wait.

Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial  Tasuku Harada, M.D., Mikio.

Similar presentations


Presentation on theme: "Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial  Tasuku Harada, M.D., Mikio."— Presentation transcript:

1 Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial  Tasuku Harada, M.D., Mikio Momoeda, M.D.  Fertility and Sterility  Volume 106, Issue 7, Pages (December 2016) DOI: /j.fertnstert Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Flow diagram of the randomized, controlled trial.
Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

3 Figure 2 Changes in the mean (±SE) dysmenorrhea and VAS scores from the pretreatment cycle to cycle 5 in the patients with (A) dysmenorrhea, (B) primary dysmenorrhea, and (C) secondary dysmenorrhea. *P<.05, **P<.01 for NPC-01 vs. placebo. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

4 Figure 3 Changes in the incidence rate of irregular uterine bleeding (not spotting) from the first treatment cycle to the fourth treatment cycle. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial  Tasuku Harada, M.D., Mikio."

Similar presentations


Ads by Google